Why Osteoarthritis Treatment Requires a Personalized Approach: Insights from New Research

Osteoarthritis (OA), traditionally viewed as a single degenerative joint disease, is now understood to encompass a diverse group of conditions characterized by distinct biological, structural, metabolic, and pain-related mechanisms. This paradigm shift is backed by a recent review led by Indian experts and published in International Orthopaedics, which emphasizes the importance of recognizing different osteoarthritis phenotypes to improve treatment outcomes.

Understanding the Complexity of Osteoarthritis

OA affects millions worldwide, yet its symptoms, disease progression, and response to treatment vary significantly among patients. The conventional one-size-fits-all treatment models often fall short because they fail to consider this heterogeneity.

According to the review titled “Osteoarthritis phenotypes: advancing precision medicine through clinical, structural, and molecular stratification,” osteoarthritis should be approached not as a uniform disease but as a syndrome with multiple distinct phenotypes. Identifying these phenotypes may enable clinicians to tailor treatments more effectively by addressing the unique underlying mechanisms involved.

Recognized Osteoarthritis Phenotypes

The review highlights several clinically relevant OA phenotypes, including:

• Inflammatory phenotype: Characterized by joint inflammation driving symptoms and disease progression.
• Metabolic phenotype: Associated with systemic metabolic factors such as obesity and diabetes influencing OA development.
• Biomechanical phenotype: Linked to joint mechanics and physical stresses leading to cartilage wear and tear.
• Cartilage-subchondral bone phenotype: Involving alterations in cartilage and the bone underneath, affecting joint integrity.
• Pain-sensitization phenotype: Where central and peripheral nervous system changes amplify pain perception beyond structural damage.
• Aging-related phenotype: Influenced by the aging process with associated cellular and tissue changes.

Emerging imaging techniques and molecular classifications are further refining our understanding of these phenotypes, providing deeper insight into disease mechanisms and opening avenues for individualized therapy.

The Role of Precision Medicine in OA Management

Dr. Raju Vaishya, lead author and Senior Consultant Orthopaedic Surgeon at Indraprastha Apollo Hospitals, New Delhi, states, “Osteoarthritis is not a uniform disease entity. Two patients with similar X-ray findings may have completely different biological pathways, symptoms, and treatment responses. Recognizing OA phenotypes is essential if we want to move toward truly personalized care.”

He envisions a future where OA treatment integrates clinical evaluation with advanced imaging, biomarkers, genomics, and AI-based tools to identify the most appropriate therapy for each patient at the right time.

Challenges and Future Directions

Despite the promising outlook for phenotype-based treatment strategies, several challenges remain:

• Overlapping phenotypes: Many patients may exhibit features of multiple phenotypes complicating classification.
• Lack of validated biomarkers: Reliable molecular markers to distinguish phenotypes are still under development.
• Inconsistent clinical trial evidence: More research is needed to confirm the effectiveness of phenotype-targeted therapies.

Dr. Abhishek Vaish, co-author of the review, emphasizes that standardized definitions and multicentric validation studies are critical steps toward routine clinical application of precision medicine in OA.

Conclusion

The evolving understanding of osteoarthritis phenotypes marks a significant advancement in the field of orthopaedics. Moving away from blanket treatment approaches to precision medicine holds great promise for improving patient outcomes by tailoring interventions according to individual disease mechanisms.

As research progresses, the integration of multimodal diagnostic tools such as clinical assessments, imaging, molecular biomarkers, and AI-powered analysis will become essential in everyday practice, enabling clinicians to offer personalized, effective therapies that address the root causes of osteoarthritis in each patient.

References

Vaishya R, Wamuyu EN, Vaish A, Handa R, Kumar D. Osteoarthritis phenotypes: advancing precision medicine through clinical, structural, and molecular stratification. Int Orthop. 2026 May 15. doi: 10.1007/s00264-026-06845-9. Epub ahead of print. PMID: 42141125.